Author/Authors :
Gürel, Emre Ordu State Hospital - Department of Cardiology, Turkey , Günaydın, Zeki Yüksel Ordu University Hospital - Department of Cardiology, Turkey , Karaoğlanoğlu, Müge Ordu State Hospital - Department of Oncology, Turkey , Kırış, Tuncay Ordu State Hospital - Department of Cardiology, Turkey
Abstract :
Axitinib is a novel tyrosine kinase inhibitor which is a second-line option for the treatment of metastatic renal cell carcinoma with progression after previous therapy (1, 2). We present the first reported case of acute myocardial infarction in a patient receiving axitinib.
